Source: iQoncept / Shutterstock
Immunovant (NASDAQ:IMVT) just reported results for the fourth quarter of 2024.
- Immunovant reported earnings per share of -52 cents. This was below the analyst estimate for EPS of -43 cents.
- The company did not report any revenue for the quarter.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/imvt-stock-earnings-immunovant-for-q4-of-2024/.
©2024 InvestorPlace Media, LLC